新生儿重症监护病房中用于心电图和心率监测的无线皮肤传感器:前瞻性可行性、安全性和准确性研究

IF 4.3 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-04-29 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1555882
Eva Senechal, Daniel Radeschi, Shasha Lv, Emilie Jeanne, Ana Saveedra Ruiz, Lydia Tao, Brittany Dulmage, Wissam Shalish, Robert Edward Kearney, Guilherme Sant'Anna
{"title":"新生儿重症监护病房中用于心电图和心率监测的无线皮肤传感器:前瞻性可行性、安全性和准确性研究","authors":"Eva Senechal, Daniel Radeschi, Shasha Lv, Emilie Jeanne, Ana Saveedra Ruiz, Lydia Tao, Brittany Dulmage, Wissam Shalish, Robert Edward Kearney, Guilherme Sant'Anna","doi":"10.3389/fbioe.2025.1555882","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Assess feasibility, safety, and accuracy of electrocardiogram (ECG) and heart rate (HR) monitoring in neonates, using a new wireless skin sensor.</p><p><strong>Methods: </strong>Prospective observational study in infants of any gestational age admitted in the neonatal intensive care unit. ECG/HR signals were simultaneously recorded from a standard wired and new wireless system with bedside annotations. Feasibility was evaluated as signal coverage, gap numbers/durations, and sources of gaps. Safety was appraised by changes in skin condition and pain after/upon wireless sensor removal. Accuracy was measured using bias and 95% limits of agreement, and the coefficient of determination. The ability of the wireless sensors to detect normal and abnormal HR values was evaluated using a Clark Error Grid. Additionally, user satisfaction from parents and nurses were appraised using a short questionnaire.</p><p><strong>Results: </strong>25 infants had 757 h of recorded signals over 96 days. ECG coverage was 99.9% [IQR: 99.9%-99.95%] for the wired vs 97.8% [IQR: 81.6%-99.9%; p < 0.00] for the wireless system, while HR coverage was 99.4% [IQR: 98.6%-99.9%] vs 89.7% [IQR: 75.6%-97.6%; p < 0.00]. Wireless ECG gaps were <5 s in 97% of cases, and HR gaps <30 s in 85%. All ECG gaps and 57% of HR gaps were due to Bluetooth disconnection (BD). 78% of BD in wireless HR were during kangaroo care (78%). Of 192 skin photographs (96 pairs), 98% were taken, showing increased but low skin scores post-removal, with median pain scores also low. Accuracy metrics showed strong agreement, with the Clark Error Grid indicating 97% of paired signals led to the same clinical outcome. Among 23 nurse and 18 parent responses, satisfaction with the wireless system was high.</p><p><strong>Conclusion: </strong>ECG and HR monitoring using a new wireless skin sensor was feasible, safe, and accurate when compared to the wired standard. Future adjustments in the technology are needed to improve signal coverage during handling and KC and test the sensors in unstable and more immature patients. Limitations included challenges in recruiting unstable neonates, variability introduced by multiple raters completing pain assessments, and inability to apply safety metrics to the wired standard of care.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1555882"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069355/pdf/","citationCount":"0","resultStr":"{\"title\":\"Wireless skin sensors for electrocardiogram and heart rate monitoring in the neonatal intensive care unit: a prospective feasibility, safety, and accuracy study.\",\"authors\":\"Eva Senechal, Daniel Radeschi, Shasha Lv, Emilie Jeanne, Ana Saveedra Ruiz, Lydia Tao, Brittany Dulmage, Wissam Shalish, Robert Edward Kearney, Guilherme Sant'Anna\",\"doi\":\"10.3389/fbioe.2025.1555882\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Assess feasibility, safety, and accuracy of electrocardiogram (ECG) and heart rate (HR) monitoring in neonates, using a new wireless skin sensor.</p><p><strong>Methods: </strong>Prospective observational study in infants of any gestational age admitted in the neonatal intensive care unit. ECG/HR signals were simultaneously recorded from a standard wired and new wireless system with bedside annotations. Feasibility was evaluated as signal coverage, gap numbers/durations, and sources of gaps. Safety was appraised by changes in skin condition and pain after/upon wireless sensor removal. Accuracy was measured using bias and 95% limits of agreement, and the coefficient of determination. The ability of the wireless sensors to detect normal and abnormal HR values was evaluated using a Clark Error Grid. Additionally, user satisfaction from parents and nurses were appraised using a short questionnaire.</p><p><strong>Results: </strong>25 infants had 757 h of recorded signals over 96 days. ECG coverage was 99.9% [IQR: 99.9%-99.95%] for the wired vs 97.8% [IQR: 81.6%-99.9%; p < 0.00] for the wireless system, while HR coverage was 99.4% [IQR: 98.6%-99.9%] vs 89.7% [IQR: 75.6%-97.6%; p < 0.00]. Wireless ECG gaps were <5 s in 97% of cases, and HR gaps <30 s in 85%. All ECG gaps and 57% of HR gaps were due to Bluetooth disconnection (BD). 78% of BD in wireless HR were during kangaroo care (78%). Of 192 skin photographs (96 pairs), 98% were taken, showing increased but low skin scores post-removal, with median pain scores also low. Accuracy metrics showed strong agreement, with the Clark Error Grid indicating 97% of paired signals led to the same clinical outcome. Among 23 nurse and 18 parent responses, satisfaction with the wireless system was high.</p><p><strong>Conclusion: </strong>ECG and HR monitoring using a new wireless skin sensor was feasible, safe, and accurate when compared to the wired standard. Future adjustments in the technology are needed to improve signal coverage during handling and KC and test the sensors in unstable and more immature patients. Limitations included challenges in recruiting unstable neonates, variability introduced by multiple raters completing pain assessments, and inability to apply safety metrics to the wired standard of care.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1555882\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069355/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1555882\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1555882","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估使用新型无线皮肤传感器监测新生儿心电图(ECG)和心率(HR)的可行性、安全性和准确性。方法:对新生儿重症监护病房收治的任何胎龄婴儿进行前瞻性观察研究。心电/HR信号同时记录从一个标准的有线和新的无线系统与床边注释。可行性评估包括信号覆盖范围、缺口数量/持续时间和缺口来源。通过移除无线传感器后皮肤状况和疼痛的变化来评估安全性。准确度采用偏倚、95%一致限和决定系数来衡量。无线传感器检测正常和异常HR值的能力使用克拉克误差网格进行评估。此外,使用一份简短的问卷对家长和护士的用户满意度进行评估。结果:25名婴儿在96天内记录了757小时的信号。有线心电图覆盖率为99.9% [IQR: 99.9%-99.95%],有线心电图覆盖率为97.8% [IQR: 81.6%-99.9%];p < 0.00], HR覆盖率为99.4% [IQR: 98.6% ~ 99.9%] vs 89.7% [IQR: 75.6% ~ 97.6%];P < 0.00]。结论:与有线标准相比,采用新型无线皮肤传感器进行心电和心率监测是可行、安全、准确的。未来需要对该技术进行调整,以提高处理和KC过程中的信号覆盖,并在不稳定和更不成熟的患者中测试传感器。限制包括招募不稳定新生儿的挑战,多个评分员完成疼痛评估带来的可变性,以及无法将安全指标应用于有线护理标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Wireless skin sensors for electrocardiogram and heart rate monitoring in the neonatal intensive care unit: a prospective feasibility, safety, and accuracy study.

Objectives: Assess feasibility, safety, and accuracy of electrocardiogram (ECG) and heart rate (HR) monitoring in neonates, using a new wireless skin sensor.

Methods: Prospective observational study in infants of any gestational age admitted in the neonatal intensive care unit. ECG/HR signals were simultaneously recorded from a standard wired and new wireless system with bedside annotations. Feasibility was evaluated as signal coverage, gap numbers/durations, and sources of gaps. Safety was appraised by changes in skin condition and pain after/upon wireless sensor removal. Accuracy was measured using bias and 95% limits of agreement, and the coefficient of determination. The ability of the wireless sensors to detect normal and abnormal HR values was evaluated using a Clark Error Grid. Additionally, user satisfaction from parents and nurses were appraised using a short questionnaire.

Results: 25 infants had 757 h of recorded signals over 96 days. ECG coverage was 99.9% [IQR: 99.9%-99.95%] for the wired vs 97.8% [IQR: 81.6%-99.9%; p < 0.00] for the wireless system, while HR coverage was 99.4% [IQR: 98.6%-99.9%] vs 89.7% [IQR: 75.6%-97.6%; p < 0.00]. Wireless ECG gaps were <5 s in 97% of cases, and HR gaps <30 s in 85%. All ECG gaps and 57% of HR gaps were due to Bluetooth disconnection (BD). 78% of BD in wireless HR were during kangaroo care (78%). Of 192 skin photographs (96 pairs), 98% were taken, showing increased but low skin scores post-removal, with median pain scores also low. Accuracy metrics showed strong agreement, with the Clark Error Grid indicating 97% of paired signals led to the same clinical outcome. Among 23 nurse and 18 parent responses, satisfaction with the wireless system was high.

Conclusion: ECG and HR monitoring using a new wireless skin sensor was feasible, safe, and accurate when compared to the wired standard. Future adjustments in the technology are needed to improve signal coverage during handling and KC and test the sensors in unstable and more immature patients. Limitations included challenges in recruiting unstable neonates, variability introduced by multiple raters completing pain assessments, and inability to apply safety metrics to the wired standard of care.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信